Curated News
By: NewsRamp Editorial Staff
June 30, 2026

TechForce Deploys LIM-E Robot at Oncotelic, Entering Pharma Automation

Discuss on Substack Discuss on Telegram View History of this news story on GitHub
Original Source

TLDR

  • TechForce Robotics enters pharma automation with LIM-E robot at Oncotelic, gaining first-mover advantage in GMP workflows.
  • LIM-E robot deployed under joint development agreement with Oncotelic, fulfilling Phase 1 objectives for GMP-regulated lab automation.
  • Automation frees researchers from routine logistics, allowing them to focus on higher-value scientific work and drug development.
  • TechForce's LIM-E robot, born in hospitality, now pivots to pharma labs via strategic alliance with JJ Enterprise for machine vision.

Impact - Why it Matters

This news matters because it signals a significant shift in pharmaceutical automation, where autonomous robots can handle routine tasks, allowing scientists and technicians to focus on critical research and production. For investors, it highlights TechForce's expansion into a high-growth sector, potentially increasing the value of NGTF stock. For the industry, it demonstrates how robotics-as-a-service can be adapted from hospitality to highly regulated environments, paving the way for scalable, efficient lab operations.

Summary

TechForce Robotics, acting as a subsidiary of Nightfood Holdings, Inc. (OTCQB: NGTF), has completed the initial deployment of its LIM-E autonomous laboratory support robot at Oncotelic Therapeutics. This marks the company's first operational entry into pharmaceutical and laboratory automation, fulfilling Phase 1 objectives under a joint development agreement. The agreement aims to evaluate robotics and AI-enhanced systems for future GMP-regulated pharmaceutical manufacturing and laboratory workflows. Additionally, a new strategic alliance with JJ Enterprise adds advanced manufacturing, machine vision, and precision engineering expertise to support the expansion of high-precision AI-driven applications.

Laboratory and pharmaceutical operations increasingly face the challenge of improving efficiency while freeing highly trained personnel for higher-value work. Researchers and technicians often spend significant time on routine logistics tasks that do not directly advance scientific work or manufacturing output. As labor costs rise and productivity demands grow, organizations are exploring automation solutions capable of supporting operational scalability without disrupting regulated workflows. TechForce Robotics is positioning itself to address this opportunity by extending its robotics-as-a-service platform from hospitality into laboratory automation, as detailed in the Read More article.

TechMediaWire (TMW) is a specialized communications platform focused on pioneering technology companies and is part of the Dynamic Brand Portfolio @ IBN. TMW delivers services including press release distribution via InvestorWire, editorial syndication to 5,000+ outlets, press release enhancement, and social media distribution. For more information, visit TechMediaWire's website. This news underscores the growing trend of automation in regulated industries, with TechForce Robotics leveraging its expertise to potentially transform pharmaceutical and laboratory workflows.

Source Statement

This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, TechForce Deploys LIM-E Robot at Oncotelic, Entering Pharma Automation

blockchain registration record for this content.